The use of positron emission tomography (PET) is well-established in the management of adult tumours. However, experience in the use of PET in the paediatric population is more limited. Children are not just small adults; they differ in their psychology, normal physiology and pathophysiology. Furthermore, different tumour entities or subtypes with different biology may be […]
Ali Vahed, Leon Menezes
UCL Institute of Nuclear Medicine
Lymphomas can be broadly divided into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). There are over 60 subtypes of NHL and in this heterogeneous group of malignancies, two of the most common subtypes are diffuse large B-cell lymphoma (DLBCL) representing the high grade or histologically aggressive lymphomas, and follicular lymphoma (FL) which is low grade […]
Dr Nagabhushan Seshadri, Dr Rashika Fernando, Dr Mark Hughes
Royal Liverpool University Hospital and Broadgreen University Hospitals NHS Trust
Hodgkin lymphoma (HL), formerly called Hodgkin disease, has attained high survival rates (≥75% at ten years for all grades and stages combined, age-standardised), with continued improvements in treatment modalities since the 1940s, when radiotherapy was first used to combat the disease. Today, sequential chemotherapy and radiation are used in many cases, but certain groups of […]
Dr H M Shaw, Dr W Topping
Mount Vernon Cancer Centre, Lister Hospital